The pathophysiology of the peritoneal membrane
- PMID: 20448020
- DOI: 10.1681/ASN.2009070694
The pathophysiology of the peritoneal membrane
Abstract
The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experimental models to test and understand critical pieces of pathophysiology. To date, the majority of studies performed in rat and rabbit models derive mechanistic insights primarily on the basis of interventional pharmacologic agents, blocking antibodies, or transient expression systems. Because body size no longer limits the performance of in vivo studies of PD, genetic mouse models are increasingly available to investigate the molecular and pathophysiologic mechanisms of the peritoneal membrane. We illustrate in this review how these investigations are catching up with other areas of biomedical research and provide direct evidence for understanding transport and ultrafiltration, responses to infection, and structural changes including fibrosis and angiogenesis. These studies are relevant to mechanisms responsible not only for the major complications of PD but also for endothelial biology, host defense, inflammation, and tissue repair processes.
Similar articles
-
Transgenic mouse models.Perit Dial Int. 2007 Nov-Dec;27(6):625-33. Perit Dial Int. 2007. PMID: 17984420 Review.
-
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.J Am Soc Nephrol. 2007 Jul;18(7):2004-13. doi: 10.1681/ASN.2006111292. Epub 2007 Jun 13. J Am Soc Nephrol. 2007. PMID: 17568021 Review.
-
Peritoneal morphological and functional changes associated with platelet-derived growth factor B.Nephrol Dial Transplant. 2009 Feb;24(2):448-57. doi: 10.1093/ndt/gfn498. Epub 2008 Sep 4. Nephrol Dial Transplant. 2009. PMID: 18775895
-
Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.Front Med. 2017 Sep;11(3):349-358. doi: 10.1007/s11684-017-0571-2. Epub 2017 Aug 8. Front Med. 2017. PMID: 28791669 Review.
-
Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.Curr Opin Investig Drugs. 2005 Mar;6(3):262-8. Curr Opin Investig Drugs. 2005. PMID: 15816502
Cited by
-
Zinc: a potential star for regulating peritoneal fibrosis.Front Pharmacol. 2024 Sep 4;15:1436864. doi: 10.3389/fphar.2024.1436864. eCollection 2024. Front Pharmacol. 2024. PMID: 39301569 Free PMC article. Review.
-
Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.PLoS One. 2016 Apr 27;11(4):e0154644. doi: 10.1371/journal.pone.0154644. eCollection 2016. PLoS One. 2016. PMID: 27119341 Free PMC article.
-
Delayed administration of suramin attenuates peritoneal fibrosis in rats.BMC Nephrol. 2019 Nov 14;20(1):411. doi: 10.1186/s12882-019-1597-2. BMC Nephrol. 2019. PMID: 31727005 Free PMC article.
-
Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.Int Urol Nephrol. 2018 Jun;50(6):1151-1161. doi: 10.1007/s11255-018-1872-3. Epub 2018 May 4. Int Urol Nephrol. 2018. PMID: 29728994 Free PMC article.
-
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.PLoS Pathog. 2011 May;7(5):e1002040. doi: 10.1371/journal.ppat.1002040. Epub 2011 May 12. PLoS Pathog. 2011. PMID: 21589907 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical